![Todd Levine](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Todd Dylan Levine is the founder of Cnd Life Sciences, Inc. He currently holds positions as Co-Director of the Neurophysiology Department at Banner-University Medical Center Phoenix and Director at Phoenix Neurological Associates Ltd.
Todd Levine active positions
Companies | Position | Start |
---|---|---|
Banner–University Medical Center Phoenix
![]() Banner–University Medical Center Phoenix Medical/Nursing ServicesHealth Services Banner–University Medical Center Phoenix provides medical care, treatment and recovery services. It offers emergency, family healthcare, laboratory, wellness, and maternity. The company is headquartered in Phoenix, AZ. | Corporate Officer/Principal | - |
Phoenix Neurological Associates Ltd.
![]() Phoenix Neurological Associates Ltd. Medical/Nursing ServicesHealth Services Phoenix Neurological Associates Ltd. engages in treating patients with neurologic diseases. It specializes in alzheimers, amyotrophic lateral sclerosis, chronic inflammatory demyelinating polyneuropathy, dermatomyositis, epilepsy, guillain barre syndrome, headache, inclusion body myositis, movement disorders, multiple sclerosis and muscular dystrophy. The company is headquartered in Phoenix, AZ. | Director/Board Member | - |
Cnd Life Sciences, Inc.
![]() Cnd Life Sciences, Inc. Medical/Nursing ServicesHealth Services Cnd Life Sciences, Inc. is a company based in an undisclosed location that aims to transform the diagnosis and treatment of neurodegenerative diseases. The company is based in Scottsdale, AZ. The company operates a CLIA-certified and CAP-accredited laboratory and has launched the Syn-One test, the world's first commercially available test that detects and visualizes phosphorylated alpha-synuclein in cutaneous nerves with high accuracy to aid the diagnosis of Parkinson's disease and related disorders. Cnd Life Sciences has scientific collaborations with biopharmaceutical companies and has been awarded three NIH SBIR grants to advance the clinical utility of the Syn-One test. The company allows clinicians to access objective pathological insights on diseases that are often difficult to diagnose and apply those insights to generate better outcomes for patients. The company was founded in 2017 by Todd Dylan Levine, Christopher Gibbons, Roy Freeman, and the CEO is Richard J. Morello. | Founder | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
Banner–University Medical Center Phoenix
![]() Banner–University Medical Center Phoenix Medical/Nursing ServicesHealth Services Banner–University Medical Center Phoenix provides medical care, treatment and recovery services. It offers emergency, family healthcare, laboratory, wellness, and maternity. The company is headquartered in Phoenix, AZ. | Health Services |
Phoenix Neurological Associates Ltd.
![]() Phoenix Neurological Associates Ltd. Medical/Nursing ServicesHealth Services Phoenix Neurological Associates Ltd. engages in treating patients with neurologic diseases. It specializes in alzheimers, amyotrophic lateral sclerosis, chronic inflammatory demyelinating polyneuropathy, dermatomyositis, epilepsy, guillain barre syndrome, headache, inclusion body myositis, movement disorders, multiple sclerosis and muscular dystrophy. The company is headquartered in Phoenix, AZ. | Health Services |
Cnd Life Sciences, Inc.
![]() Cnd Life Sciences, Inc. Medical/Nursing ServicesHealth Services Cnd Life Sciences, Inc. is a company based in an undisclosed location that aims to transform the diagnosis and treatment of neurodegenerative diseases. The company is based in Scottsdale, AZ. The company operates a CLIA-certified and CAP-accredited laboratory and has launched the Syn-One test, the world's first commercially available test that detects and visualizes phosphorylated alpha-synuclein in cutaneous nerves with high accuracy to aid the diagnosis of Parkinson's disease and related disorders. Cnd Life Sciences has scientific collaborations with biopharmaceutical companies and has been awarded three NIH SBIR grants to advance the clinical utility of the Syn-One test. The company allows clinicians to access objective pathological insights on diseases that are often difficult to diagnose and apply those insights to generate better outcomes for patients. The company was founded in 2017 by Todd Dylan Levine, Christopher Gibbons, Roy Freeman, and the CEO is Richard J. Morello. | Health Services |
- Stock Market
- Insiders
- Todd Levine